Comments
Loading...
89bio (NASDAQ:ETNB) Stock Quotes, Forecast and News Summary
89bio Stock (NASDAQ: ETNB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy 89bio (ETNB) stock?
You can purchase shares of 89bio (NASDAQ:ETNB) through any online brokerage.
Who are 89bio (ETNB) competitors?
Other companies in 89bio’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Syndax Pharmaceuticals (NASDAQ:SNDX), Arcutis Biotherapeutics (NASDAQ:ARQT), Agios Pharmaceuticals (NASDAQ:AGIO) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
What is the forecast, or price target, for 89bio (ETNB) stock?
89bio has a consensus price target of $30.50.
What is the current price for 89bio (ETNB)?
The stock price for 89bio (NASDAQ: ETNB) is $10.94 last updated February 21, 2025 at 10:41 AM EST.
Does 89bio (ETNB) pay a dividend?
There are no upcoming dividends for 89bio.
When is 89bio (NASDAQ:ETNB) reporting earnings?
89bio’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is 89bio (ETNB) going to split?
There is no upcoming split for 89bio.
What sector and industry does 89bio (ETNB) operate in?
89bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.